Multiple Doses of AT-1501-A201 in Adults With ALS

A Phase 2a Open-Label, Multi-Center Study to Evaluate the Safety and Tolerability of Multiple Doses of AT-1501 in Adults With ALS

Location: San Francisco (CPMC)

Please contact: clinicalresearch@sutterhealth.org about study Multiple Doses of AT-1501-A201 in Adults With ALS

Principal Investigator

Jonathan Katz, M.D.

Co-Investigator(s)

Robert Miller, M.D., Liberty Jenkins, MD 

Recruitment Status

Active, Recruiting